-
Je něco špatně v tomto záznamu ?
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway
S. Grusanovic, P. Danek, M. Kuzmina, MK. Adamcova, M. Burocziova, R. Mikyskova, K. Vanickova, S. Kosanovic, J. Pokorna, M. Reinis, T. Brdicka, M. Alberich-Jorda
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2000 do Před 1 rokem
PubMed Central
od 2000
Europe PubMed Central
od 2000 do Před 1 rokem
Open Access Digital Library
od 2000-07-01
Medline Complete (EBSCOhost)
od 2000-07-01 do Před 1 rokem
Wiley Free Content
od 2000 do Před 1 rokem
PubMed
36341527
DOI
10.15252/embr.202254729
Knihovny.cz E-zdroje
- MeSH
- hematopoetické kmenové buňky metabolismus MeSH
- hematopoéza MeSH
- interleukin-6 * genetika metabolismus MeSH
- lidé MeSH
- myši MeSH
- signální transdukce MeSH
- transkripční faktor STAT3 genetika metabolismus MeSH
- zánět * metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Chronic inflammation represents a major threat to human health since long-term systemic inflammation is known to affect distinct tissues and organs. Recently, solid evidence demonstrated that chronic inflammation affects hematopoiesis; however, how chronic inflammation affects hematopoietic stem cells (HSCs) on the mechanistic level is poorly understood. Here, we employ a mouse model of chronic multifocal osteomyelitis (CMO) to assess the effects of a spontaneously developed inflammatory condition on HSCs. We demonstrate that hematopoietic and nonhematopoietic compartments in CMO BM contribute to HSC expansion and impair their function. Remarkably, our results suggest that the typical features of murine multifocal osteomyelitis and the HSC phenotype are mechanistically decoupled. We show that the CMO environment imprints a myeloid gene signature and imposes a pro-inflammatory profile on HSCs. We identify IL-6 and the Jak/Stat3 signaling pathway as critical mediators. However, while IL-6 and Stat3 blockage reduce HSC numbers in CMO mice, only inhibition of Stat3 activity significantly rescues their fitness. Our data emphasize the detrimental effects of chronic inflammation on stem cell function, opening new venues for treatment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004638
- 003
- CZ-PrNML
- 005
- 20231213144537.0
- 007
- ta
- 008
- 230418s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.15252/embr.202254729 $2 doi
- 035 __
- $a (PubMed)36341527
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Grusanovic, Srdjan $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $u Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000151349630
- 245 10
- $a Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway / $c S. Grusanovic, P. Danek, M. Kuzmina, MK. Adamcova, M. Burocziova, R. Mikyskova, K. Vanickova, S. Kosanovic, J. Pokorna, M. Reinis, T. Brdicka, M. Alberich-Jorda
- 520 9_
- $a Chronic inflammation represents a major threat to human health since long-term systemic inflammation is known to affect distinct tissues and organs. Recently, solid evidence demonstrated that chronic inflammation affects hematopoiesis; however, how chronic inflammation affects hematopoietic stem cells (HSCs) on the mechanistic level is poorly understood. Here, we employ a mouse model of chronic multifocal osteomyelitis (CMO) to assess the effects of a spontaneously developed inflammatory condition on HSCs. We demonstrate that hematopoietic and nonhematopoietic compartments in CMO BM contribute to HSC expansion and impair their function. Remarkably, our results suggest that the typical features of murine multifocal osteomyelitis and the HSC phenotype are mechanistically decoupled. We show that the CMO environment imprints a myeloid gene signature and imposes a pro-inflammatory profile on HSCs. We identify IL-6 and the Jak/Stat3 signaling pathway as critical mediators. However, while IL-6 and Stat3 blockage reduce HSC numbers in CMO mice, only inhibition of Stat3 activity significantly rescues their fitness. Our data emphasize the detrimental effects of chronic inflammation on stem cell function, opening new venues for treatment.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a myši $7 D051379
- 650 12
- $a interleukin-6 $x genetika $x metabolismus $7 D015850
- 650 12
- $a zánět $x metabolismus $7 D007249
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a hematopoéza $7 D006410
- 650 _2
- $a hematopoetické kmenové buňky $x metabolismus $7 D006412
- 650 _2
- $a transkripční faktor STAT3 $x genetika $x metabolismus $7 D050796
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Daněk, Petr, $d 1991- $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000265522219 $7 xx0311519
- 700 1_
- $a Kuzmina, Maria $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000153737653
- 700 1_
- $a Adamcova, Miroslava K $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000150258155 $7 xx0205682
- 700 1_
- $a Burocziova, Monika $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000314084797
- 700 1_
- $a Mikyskova, Romana $u Department of Immunological and Tumor models, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000268571155
- 700 1_
- $a Vanickova, Karolina $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000347086772
- 700 1_
- $a Kosanovic, Sladjana $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000239144998
- 700 1_
- $a Pokorna, Jana $u Department of Leukocyte signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Reinis, Milan $u Department of Immunological and Tumor models, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000170832898
- 700 1_
- $a Brdicka, Tomas $u Department of Leukocyte signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000215604398 $7 xx0140497
- 700 1_
- $a Alberich-Jorda, Meritxell $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/000000028093641X
- 773 0_
- $w MED00006590 $t EMBO reports $x 1469-3178 $g Roč. 24, č. 1 (2023), s. e54729
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36341527 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20231213144533 $b ABA008
- 999 __
- $a ok $b bmc $g 1924995 $s 1190847
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 24 $c 1 $d e54729 $e 20221107 $i 1469-3178 $m Embo reports $n EMBO Rep $x MED00006590
- LZP __
- $a Pubmed-20230418